Status:

COMPLETED

Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma

Lead Sponsor:

Technical University of Munich

Collaborating Sponsors:

Helmholtz Zentrum München

Conditions:

Metabolomics

Critical Care

Eligibility:

All Genders

18+ years

Brief Summary

In this mono-center pilot trial, polytrauma patients admitted to intensive care will be included. Investigators are going to take blood and muscle samples at respecified time points to do metabolic, h...

Eligibility Criteria

Inclusion

  • acute polytrauma patient
  • age ≥ 18 years old
  • expected intensive care stay ≥ 3 days
  • American Society of Anesthesiologists classification I or II

Exclusion

  • patient had received cardiopulmonary resuscitation
  • limitation of therapy or comfort care

Key Trial Info

Start Date :

March 24 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 22 2020

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03819959

Start Date

March 24 2019

End Date

April 22 2020

Last Update

October 6 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klinikum rechts der Isar, School of Medicine, Technical University of Munich

Munich, Bavaria, Germany, 81675

Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma | DecenTrialz